UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SCORE Study Report 1: Baseline Associations between Central Retinal Thickness and Visual Acuity in Patients with Retinal Vein Occlusion

Ophthalmology (Rochester, Minn.), 2009-03, Vol.116 (3), p.504-512

2009

Volltextzugriff (PDF)

Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion: Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Report 10

Ophthalmology (Rochester, Minn.), 2011-02, Vol.118 (2), p.345-352

2011

Volltextzugriff (PDF)

SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients with Central Retinal Vein Occlusion

American journal of ophthalmology, 2016-10, Vol.170, p.25-31

2016

Volltextzugriff (PDF)

Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2017-05, Vol.317 (20), p.2072

2017

Volltextzugriff (PDF)

Association of Retinal Thickness at Month 1 Postrandomization With Later Thickness and Visual Acuity in Central Vein Occlusion

American journal of ophthalmology, 2024-10, Vol.266, p.110-117

2024

Volltextzugriff (PDF)

Association of Retinal Thickness at Month 1 Post-Treatment with Later Thickness and Visual Acuity in Central Vein Occlusion

American journal of ophthalmology, 2024-05

2024

Volltextzugriff (PDF)

OCT Grading System of Macular Infarction Predicts Vision in Participants With Central Retinal or Hemiretinal Vein Occlusion: A Secondary Analysis of SCORE2

American journal of ophthalmology, 2023-12, Vol.256, p.55-62

2023

Volltextzugriff (PDF)

Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion

American journal of ophthalmology, 2024-04, Vol.260, p.147-159

2024

Volltextzugriff (PDF)

Month 60 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion

American journal of ophthalmology, 2022-08, Vol.240, p.330-341

2022

Volltextzugriff (PDF)

Molecular genetic findings and clinical correlations in 100 patients with Joubert syndrome and related disorders prospectively evaluated at a single center

Genetics in medicine, 2017-08, Vol.19 (8), p.875-882

2017

Volltextzugriff (PDF)

Intraocular Pressure in Eyes With Retinal Vein Occlusion Compared With Fellow Eyes: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 27

JAMA ophthalmology, 2023-12, Vol.141 (12), p.1172

2023

Volltextzugriff (PDF)

SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion

Ophthalmology (Rochester, Minn.), 2023-10, Vol.130 (10), p.1066-1072

2023

Volltextzugriff (PDF)

Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial

JAMA internal medicine, 2014-11, Vol.174 (11), p.1736

2014

Volltextzugriff (PDF)

SCORE2 Report 20: Relationship of Treatment Discontinuation With Visual Acuity and Central Subfield Thickness Outcomes

American journal of ophthalmology, 2023-04, Vol.248, p.157-163

2023

Volltextzugriff (PDF)

Feasibility and safety of extended‐release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial

Addiction (Abingdon, England), 2017-06, Vol.112 (6), p.1036-1044

2017

Volltextzugriff (PDF)

Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4

JAMA ophthalmology, 2017-06, Vol.135 (6), p.639

2017

Volltextzugriff (PDF)

SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials

American journal of ophthalmology, 2021-02, Vol.222, p.185-193

2021

Volltextzugriff (PDF)

SCORE2 Report 17: Macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusion

Graefe's archive for clinical and experimental ophthalmology, 2022-05, Vol.260 (5), p.1491-1500

2022

Volltextzugriff (PDF)

SCORE2 Report 2: Study Design and Baseline Characteristics

Ophthalmology (Rochester, Minn.), 2017-02, Vol.124 (2), p.245-256

2017

Volltextzugriff (PDF)

Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study

JAMA ophthalmology, 2019-03, Vol.137 (3), p.281

2019

Volltextzugriff (PDF)

Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15

JAMA ophthalmology, 2015-09, Vol.133 (9), p.1022

2015

Volltextzugriff (PDF)

Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents: SCORE2 report 12: secondary analysis of the SCORE2 clinical trial

Graefe's archive for clinical and experimental ophthalmology, 2021-07, Vol.259 (7), p.1839-1851

2021

Volltextzugriff (PDF)

SCORE Study Report 2: Interobserver Agreement between Investigator and Reading Center Classification of Retinal Vein Occlusion Type

Ophthalmology (Rochester, Minn.), 2009-04, Vol.116 (4), p.756-761

2009

Volltextzugriff (PDF)

SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

American journal of ophthalmology, 2017-12, Vol.184, p.147-156

2017

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(139)

Sprache

Englisch
(139)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Life Sciences & Biomedicine
(81)
Humans
(75)
Ophthalmology
(40)
Female
(39)
Male
(39)
Middle Aged
(24)
Adult
(21)
Retinal Vein Occlusion - Complications
(20)
Biological And Medical Sciences
(19)
Gene Frequency
(19)
Retinal Vein Occlusion - Drug Therapy
(19)
Tomography, Optical Coherence
(19)
Aged
(18)
Intravitreal Injections
(18)
Treatment Outcome
(17)
Macular Edema - Drug Therapy
(16)
Macular Edema - Etiology
(16)
Medical Sciences
(16)
Retinal Vein Occlusion - Diagnosis
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

SCORE Study Report 1: Baseline Associations between Central Retinal Thickness and Visual Acuity in Patients with Retinal Vein Occlusion

Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion: Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Report 10

SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients with Central Retinal Vein Occlusion

Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial

Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum

Association of Retinal Thickness at Month 1 Postrandomization With Later Thickness and Visual Acuity in Central Vein Occlusion

Association of Retinal Thickness at Month 1 Post-Treatment with Later Thickness and Visual Acuity in Central Vein Occlusion

OCT Grading System of Macular Infarction Predicts Vision in Participants With Central Retinal or Hemiretinal Vein Occlusion: A Secondary Analysis of SCORE2

Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion

Month 60 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion

Molecular genetic findings and clinical correlations in 100 patients with Joubert syndrome and related disorders prospectively evaluated at a single center

Intraocular Pressure in Eyes With Retinal Vein Occlusion Compared With Fellow Eyes: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 27

SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion

Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial

SCORE2 Report 20: Relationship of Treatment Discontinuation With Visual Acuity and Central Subfield Thickness Outcomes

Feasibility and safety of extended‐release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial

Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4

SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials

SCORE2 Report 17: Macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusion

SCORE2 Report 2: Study Design and Baseline Characteristics

Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study

Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15

Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents: SCORE2 report 12: secondary analysis of the SCORE2 clinical trial

SCORE Study Report 2: Interobserver Agreement between Investigator and Reading Center Classification of Retinal Vein Occlusion Type

SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

Suchergebnisse filtern